STRATA Skin Sciences, Inc.(SSKN)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-12-31.

STRATA Skin Sciences, Inc. (SSKN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SSKN at 19.3/100 on a 32-signal composite quality model, placing it at rank #2,664 of 2,819 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue scale (6.9) and balance sheet strength (11.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 40.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q4 2025), STRATA Skin Sciences, Inc. reports quarterly revenue of $9.3M, net income of $58.0K, free cash flow of $-551.0K. Top institutional holders of SSKN by reported 13-F value include 22NW, Nantahala Capital Management, RENAISSANCE TECHNOLOGIES, based on the most recent SEC filings. SSKN trades on the Nasdaq exchange and files with the SEC under CIK 1051514. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SSKN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for STRATA Skin Sciences, Inc. directly from SEC EDGAR.